OPKO Health Other Long-Term Assets 2010-2024 | OPK

OPKO Health other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
OPKO Health Annual Other Long-Term Assets
(Millions of US $)
2023 $204
2022 $204
2021 $600
2020 $600
2019 $597
2018 $643
2017 $653
2016 $650
2015 $797
2014 $799
2013 $800
2012 $14
2011 $1
2010 $0
2009 $0
OPKO Health Quarterly Other Long-Term Assets
(Millions of US $)
2024-06-30 $203
2024-03-31 $204
2023-12-31 $204
2023-09-30 $204
2023-06-30 $204
2023-03-31 $203
2022-12-31 $204
2022-09-30 $205
2022-06-30 $204
2022-03-31 $9
2021-12-31 $600
2021-09-30 $599
2021-06-30 $600
2021-03-31 $600
2020-12-31 $600
2020-09-30 $596
2020-06-30 $598
2020-03-31 $597
2019-12-31 $597
2019-09-30 $641
2019-06-30 $639
2019-03-31 $639
2018-12-31 $643
2018-09-30 $656
2018-06-30 $651
2018-03-31 $652
2017-12-31 $653
2017-09-30 $687
2017-06-30 $685
2017-03-31 $684
2016-12-31 $650
2016-09-30 $651
2016-06-30 $610
2016-03-31 $798
2015-12-31 $797
2015-09-30 $915
2015-06-30 $818
2015-03-31 $798
2014-12-31 $799
2014-09-30 $798
2014-06-30 $798
2014-03-31 $800
2013-12-31 $800
2013-09-30 $800
2013-06-30 $206
2013-03-31 $206
2012-12-31 $14
2012-09-30 $2
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.130B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $233.063B 27.94
Intuitive Surgical (ISRG) United States $171.313B 97.00
Alcon (ALC) Switzerland $47.672B 33.56
IQVIA Holdings (IQV) United States $44.239B 25.07
IDEXX Laboratories (IDXX) United States $42.083B 50.62
Edwards Lifesciences (EW) United States $40.680B 26.07
DexCom (DXCM) United States $27.834B 39.69
STERIS (STE) Ireland $23.508B 27.43
SONOVA HOLDING (SONVY) Switzerland $20.781B 0.00
Waters (WAT) United States $19.789B 29.50
Hologic (HOLX) United States $18.981B 20.64
Sysmex ADR (SSMXY) Japan $12.317B 38.62
Fresenius Medical Care AG KGaA (FMS) Germany $12.224B 13.70
Teleflex (TFX) United States $11.380B 17.69
Globus Medical (GMED) United States $9.423B 26.36
Penumbra (PEN) United States $7.597B 78.86
Glaukos (GKOS) United States $6.721B 0.00
Masimo (MASI) United States $6.081B 32.57
TransMedics (TMDX) United States $5.203B 222.80
PROCEPT BioRobotics (PRCT) United States $4.309B 0.00
Integer Holdings (ITGR) United States $4.304B 25.17
Tandem Diabetes Care (TNDM) United States $2.791B 0.00
LivaNova (LIVN) United Kingdom $2.773B 16.26
Veracyte (VCYT) United States $2.593B 160.76
Inari Medical (NARI) United States $2.586B 0.00
Elekta AB (EKTAY) Sweden $2.562B 20.88
Nihon Kohden (NHNKY) Japan $2.508B 15.61
RxSight (RXST) United States $2.003B 0.00
Integra LifeSciences Holdings (IART) United States $1.360B 6.19
Pulse Biosciences (PLSE) United States $1.163B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.112B 19.84
Artivion (AORT) United States $1.046B 96.04
Alphatec Holdings (ATEC) United States $0.864B 0.00
OrthoPediatrics (KIDS) United States $0.728B 0.00
Mesa Laboratories (MLAB) United States $0.682B 17.23
SiBone (SIBN) United States $0.654B 0.00
AxoGen (AXGN) United States $0.638B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.616B 0.00
IRadimed (IRMD) United States $0.614B 33.19
Paragon 28 (FNA) United States $0.581B 0.00
Pacific Biosciences Of California (PACB) United States $0.526B 0.00
Treace Medical Concepts (TMCI) United States $0.341B 0.00
Sight Sciences (SGHT) United States $0.330B 0.00
Tactile Systems Technology (TCMD) United States $0.327B 9.98
ClearPoint Neuro (CLPT) United States $0.322B 0.00
AngioDynamics (ANGO) United States $0.306B 0.00
Inogen (INGN) United States $0.253B 0.00
Delcath Systems (DCTH) United States $0.251B 0.00
Nevro (NVRO) United States $0.217B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.190B 0.00
CVRx (CVRX) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.179B 0.00
Semler Scientific (SMLR) United States $0.173B 12.15
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.135B 0.00
908 Devices (MASS) United States $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.122B 0.00
EDAP TMS S.A (EDAP) France $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.103B 0.00
Sensus Healthcare (SRTS) United States $0.099B 14.81
Hyperfine (HYPR) United States $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
LENSAR (LNSR) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Adagio Medical Holdings (ADGM) United States $0.032B 0.00
Neuronetics (STIM) United States $0.029B 0.00
Lifeward (LFWD) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.010B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00